about
Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury.Clinical outcome of critically ill patients with thrombocytopenia and hypophosphatemia in the early stage of sepsis.Establishment of an animal model of depression contagion.Brain to blood glutamate scavenging as a novel therapeutic modality: a reviewAnesthetic Management of Patients with Congenital Insensitivity to Pain with Anhidrosis: A Retrospective Analysis of 358 Procedures Performed Under General AnesthesiaExtracorporeal methods of blood glutamate scavenging: a novel therapeutic modality.Distinctive gene expression profile in women with history of postpartum depression.The incidence of hyperthermia during cochlear implant surgery in children.Effects of Acute Lithium Treatment on Brain Levels of Inflammatory Mediators in Poststroke Rats.Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats.The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage.Bedside Percutaneous Tracheostomy versus Open Surgical Tracheostomy in Non-ICU Patients.The neuro-behavioral profile in rats after subarachnoid hemorrhage.Distribution of radiolabeled l-glutamate and d-aspartate from blood into peripheral tissues in naive rats: significance for brain neuroprotection.Regulation of blood L-glutamate levels by stress as a possible brain defense mechanism.Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats.Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke.Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients.Treatment of combined traumatic brain injury and hemorrhagic shock with fractionated blood products versus fresh whole blood in a rat model.Anatomical location of arterial and venous lines significantly affects motor performance in rats.β2 adrenergic-mediated reduction of blood glutamate levels and improved neurological outcome after traumatic brain injury in rats.A New Method for Inducing a Depression-Like Behavior in Rats.The effects of estrogen and progesterone on blood glutamate levels during normal pregnancy in womenAn Alternative Model of Laser-Induced Stroke in the Motor Cortex of RatsThe activation of β2-adrenergic receptors in naïve rats causes a reduction of blood glutamate levels: relevance to stress and neuroprotectionDetermination of factors affecting glutamate concentrations in the whole blood of healthy human volunteersMorphological and neuro-behavioral parallels in the rat model of strokeCell-free DNA--a marker to predict ischemic brain damage in a rat stroke experimental modelThe effects of hemodialysis on blood glutamate levels in chronic renal failure: implementation for neuroprotectionThe effects of peritoneal dialysis on blood glutamate levels: implementation for neuroprotectionBiological and Behavioral Patterns of Post-Stroke Depression in RatsBlood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depressionEstablishment of novel technical methods for evaluating brain edema and lesion volume in stroked rats: A standardization of measurement proceduresThe effect of depressive-like behavior and antidepressant therapy on social behavior and hierarchy in ratsThe effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approachA Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
P50
Q30364414-8D718692-1A19-437B-9D03-565F52BBEE28Q33436705-8709C94C-D826-4A05-81C8-EF04343E9071Q35009656-75A0FA5E-4899-412E-8A21-E22668C85A6CQ35241461-E033C139-511F-4ED6-8DD1-57170ED85698Q36328093-B86766BD-F6D6-4C34-8A95-921AE8E01FC4Q36338394-DA0547C6-0CDC-46F7-BB69-67600EE8B35BQ39212466-C6164F7B-9FFD-4EB1-8F56-50D83D27A447Q40043414-4434A017-3FD6-4CB3-BB7C-A2EF42D479D3Q40134274-3026D974-B104-4391-8B35-1D770DCC9046Q40707142-7030BF76-35FA-489E-A6CA-3CF95D8E4C2AQ41834503-274BBA87-E74B-4154-B3DC-6C96ABE5601DQ41912653-9EF3504C-36CC-470F-BAC3-FD586ACBBFF7Q42675182-F366AB58-CD1B-4C52-905A-7CFD6BC68DDEQ42943993-87E47D2E-6C07-4FB7-AFFA-931186641762Q43056641-196DE720-FE18-4439-8B46-07F8887E2681Q47323444-36F9FA8D-D012-44F6-B4CB-EEA486FFF609Q47578340-66602BEB-C6A9-4C67-8F8B-99CC764233A4Q47579241-F6E78E87-6DCD-4DCC-A4EF-18DE633E4D44Q47805688-C3FE1B48-0647-48F3-855D-E1819E550192Q47854823-E61B211D-0942-4453-AD22-542381722CEAQ48390393-40E21753-11B0-4299-A760-9986163D97B8Q48858011-5E6EABDE-AC50-4407-892D-CCB2E9BF0E1FQ52649059-9DF318E5-1499-49BC-8662-E4DCF50BE0DFQ61850017-5D2861DF-44AE-4D28-B360-44531DE58A14Q64052899-12AA2A36-F451-4583-A0CB-5DC386629960Q83131154-4BF05724-7D35-498B-91A8-95236E2E9C31Q83240148-A71C8AF9-98E5-4C73-B7FC-9B07C20FAFC4Q83654077-2CF43470-064E-403E-8F7B-7221C85955E0Q84143474-3E5173AF-5D69-4550-8721-E05F25DFC53DQ85236667-B46A859B-02E5-419F-ABD6-FD7DB51A3332Q86927535-79C58F54-87C7-4711-BEC8-D7364DCEB82FQ89028647-EB5778FF-5914-4940-9E78-FD29038E2CE6Q89941156-D56F6BCA-6CC2-4EC5-864F-E433F7F5BED7Q91543832-839846F5-A6FE-4FA7-9FA6-8A3CC1DD88EAQ92158539-FA50311C-61BB-4788-9666-B6826743BAF8Q92462754-959CC2B1-3156-487F-B61D-1DE04ED75F14Q92627553-A638D8DA-6987-49FE-8CCB-8D90663A2D4C
P50
description
researcher ORCID ID = 0000-0003-3116-1643
@en
wetenschapper
@nl
name
Matthew Boyko
@ast
Matthew Boyko
@en
Matthew Boyko
@es
Matthew Boyko
@nl
type
label
Matthew Boyko
@ast
Matthew Boyko
@en
Matthew Boyko
@es
Matthew Boyko
@nl
prefLabel
Matthew Boyko
@ast
Matthew Boyko
@en
Matthew Boyko
@es
Matthew Boyko
@nl
P1153
36338731800
P31
P496
0000-0003-3116-1643